Retatrutide Calculator
The retatrutide calculator works out what a given volume of bacteriostatic water does to a research-grade retatrutide vial’s concentration, and how many U-100 syringe units a given amount takes. It is worked for the retatrutide vial sizes tracked across vendors, not generic examples, and it does not set a dose.
Vial strength and water volume give a concentration; a dose then gives the unit mark it corresponds to.
Always verify calculations independently before use.
What reconstitution is
Retatrutide, like other research peptides, ships from vendors as a lyophilized (freeze-dried) powder sealed in a vial. Reconstitution is the act of dissolving that powder in a liquid — typically bacteriostatic water — which turns a fixed mass of peptide (the vial’s labeled mg content) into a solution with a defined concentration, measurable in volume with a syringe. The mass doesn’t change; only how that mass is distributed through a volume of liquid changes.
Retatrutide is investigational, so there is no manufacturer instruction for reconstituting it. The math below is generic pharmaceutical arithmetic (concentration = mass ÷ volume), the same relationship that governs any lyophilized compound dissolved in a diluent, applied to the vial sizes retatrutide is actually sold in. For the compound’s mechanism (a triple GIP/GLP-1/glucagon receptor agonist) and trial evidence, see the retatrutide profile.
What sizes does retatrutide come in?
Eleven sizes, from 5 mg to 60 mg, are each carried by three or more of the vendors tracked here — the sizes with a real, multi-vendor market rather than one vendor’s own catalog choice. They are listed below with the number of vendors carrying each, read from live price data rather than a list kept by hand, which is why the calculator above offers exactly these as one-tap sizes. A handful of vendors (notably one carrying an unusually wide, closely-spaced ladder) sell additional odd-numbered sizes not shown here; the arithmetic applies to any size the same way.
| Vial size | Vendors tracking this size |
|---|---|
| 5 mg | 8 |
| 6 mg | 4 |
| 10 mg | 36 |
| 12 mg | 5 |
| 15 mg | 9 |
| 20 mg | 24 |
| 24 mg | 4 |
| 30 mg | 28 |
| 40 mg | 6 |
| 50 mg | 10 |
| 60 mg | 11 |
The arithmetic, worked
Concentration (mg/mL) equals the vial’s total mg divided by the water volume in mL. Micrograms per syringe unit, on a U-100 syringe (100 units = 1 mL), equals that concentration multiplied by 10. The table below reports both figures at two illustrative water volumes for each tracked size — as a statement of what each volume does to the concentration, not a recommendation of either:
| Vial size | At 1 mL water | At 2 mL water |
|---|---|---|
| 5 mg | 5 mg/mL — 50 mcg/unit | 2.5 mg/mL — 25 mcg/unit |
| 6 mg | 6 mg/mL — 60 mcg/unit | 3 mg/mL — 30 mcg/unit |
| 10 mg | 10 mg/mL — 100 mcg/unit | 5 mg/mL — 50 mcg/unit |
| 12 mg | 12 mg/mL — 120 mcg/unit | 6 mg/mL — 60 mcg/unit |
| 15 mg | 15 mg/mL — 150 mcg/unit | 7.5 mg/mL — 75 mcg/unit |
| 20 mg | 20 mg/mL — 200 mcg/unit | 10 mg/mL — 100 mcg/unit |
| 24 mg | 24 mg/mL — 240 mcg/unit | 12 mg/mL — 120 mcg/unit |
| 30 mg | 30 mg/mL — 300 mcg/unit | 15 mg/mL — 150 mcg/unit |
| 40 mg | 40 mg/mL — 400 mcg/unit | 20 mg/mL — 200 mcg/unit |
| 50 mg | 50 mg/mL — 500 mcg/unit | 25 mg/mL — 250 mcg/unit |
| 60 mg | 60 mg/mL — 600 mcg/unit | 30 mg/mL — 300 mcg/unit |
Doubling the water volume halves the concentration and halves the mcg delivered per unit drawn — the relationship is linear in both directions. The general dosage calculator runs this same arithmetic for any vial size and water volume, including ones outside the table above, and the how much bac water for retatrutide FAQ sets it out as a reference table.
Units to draw, by vial size and dose
Every cell is the U-100 unit mark a given dose comes to, for a given vial strength, at 2 mL of bacteriostatic water. The rows are the vial sizes three or more tracked vendors carry; the columns are round dose values, chosen so the table reads cleanly across that range. They are not a schedule and nothing here suggests one — the doses clinics publish and retatrutide’s trial doses are set out in the retatrutide dosage guide.
| Vial | 1,000 mcg(1 mg) | 2,000 mcg(2 mg) | 3,000 mcg(3 mg) | 4,000 mcg(4 mg) | 6,000 mcg(6 mg) | 8,000 mcg(8 mg) | 10,000 mcg(10 mg) | 12,000 mcg(12 mg) |
|---|---|---|---|---|---|---|---|---|
| 5 mg | 40.0 | 80.0 | 120.0 | 160.0 | 240.0 | 320.0 | 400.0 | 480.0 |
| 6 mg | 33.3 | 66.7 | 100.0 | 133.3 | 200.0 | 266.7 | 333.3 | 400.0 |
| 10 mg | 20.0 | 40.0 | 60.0 | 80.0 | 120.0 | 160.0 | 200.0 | 240.0 |
| 12 mg | 16.7 | 33.3 | 50.0 | 66.7 | 100.0 | 133.3 | 166.7 | 200.0 |
| 15 mg | 13.3 | 26.7 | 40.0 | 53.3 | 80.0 | 106.7 | 133.3 | 160.0 |
| 20 mg | 10.0 | 20.0 | 30.0 | 40.0 | 60.0 | 80.0 | 100.0 | 120.0 |
| 24 mg | 8.3 | 16.7 | 25.0 | 33.3 | 50.0 | 66.7 | 83.3 | 100.0 |
| 30 mg | 6.7 | 13.3 | 20.0 | 26.7 | 40.0 | 53.3 | 66.7 | 80.0 |
| 40 mg | 5.0 | 10.0 | 15.0 | 20.0 | 30.0 | 40.0 | 50.0 | 60.0 |
| 50 mg | 4.0 | 8.0 | 12.0 | 16.0 | 24.0 | 32.0 | 40.0 | 48.0 |
| 60 mg | 3.3 | 6.7 | 10.0 | 13.3 | 20.0 | 26.7 | 33.3 | 40.0 |
Figures over 100 are shown in amber: they exceed a 1 mL U-100 barrel at this water volume, so that combination does not fit one syringe. More water lowers the concentration and raises the unit count; less water does the reverse. The calculator above works any vial, volume and dose, in either direction.
What one vial comes to
The three sizes the most tracked vendors carry, worked at 2 mL. “Doses per vial” is the vial’s total divided by the dose — how many times that amount is present in the vial, before any loss in handling.
10 mg vial at 2 mL — 5.00 mg/mL
| Dose | Units to draw | Draw volume | Doses per vial |
|---|---|---|---|
| 1,000 mcg (1 mg) | 20.0 | 0.20 mL | 10.0 |
| 2,000 mcg (2 mg) | 40.0 | 0.40 mL | 5.0 |
| 3,000 mcg (3 mg) | 60.0 | 0.60 mL | 3.3 |
| 4,000 mcg (4 mg) | 80.0 | 0.80 mL | 2.5 |
| 6,000 mcg (6 mg) | 120.0 | 1.20 mL | 1.7 |
| 8,000 mcg (8 mg) | 160.0 | 1.60 mL | 1.3 |
| 10,000 mcg (10 mg) | 200.0 | 2.00 mL | 1.0 |
| 12,000 mcg (12 mg) | 240.0 | 2.40 mL | 0.8 |
30 mg vial at 2 mL — 15.00 mg/mL
| Dose | Units to draw | Draw volume | Doses per vial |
|---|---|---|---|
| 1,000 mcg (1 mg) | 6.7 | 0.07 mL | 30.0 |
| 2,000 mcg (2 mg) | 13.3 | 0.13 mL | 15.0 |
| 3,000 mcg (3 mg) | 20.0 | 0.20 mL | 10.0 |
| 4,000 mcg (4 mg) | 26.7 | 0.27 mL | 7.5 |
| 6,000 mcg (6 mg) | 40.0 | 0.40 mL | 5.0 |
| 8,000 mcg (8 mg) | 53.3 | 0.53 mL | 3.8 |
| 10,000 mcg (10 mg) | 66.7 | 0.67 mL | 3.0 |
| 12,000 mcg (12 mg) | 80.0 | 0.80 mL | 2.5 |
20 mg vial at 2 mL — 10.00 mg/mL
| Dose | Units to draw | Draw volume | Doses per vial |
|---|---|---|---|
| 1,000 mcg (1 mg) | 10.0 | 0.10 mL | 20.0 |
| 2,000 mcg (2 mg) | 20.0 | 0.20 mL | 10.0 |
| 3,000 mcg (3 mg) | 30.0 | 0.30 mL | 6.7 |
| 4,000 mcg (4 mg) | 40.0 | 0.40 mL | 5.0 |
| 6,000 mcg (6 mg) | 60.0 | 0.60 mL | 3.3 |
| 8,000 mcg (8 mg) | 80.0 | 0.80 mL | 2.5 |
| 10,000 mcg (10 mg) | 100.0 | 1.00 mL | 2.0 |
| 12,000 mcg (12 mg) | 120.0 | 1.20 mL | 1.7 |
What changes the answer
- Water volume. Concentration is inversely proportional to water volume — the table above shows this directly. A larger water volume produces a lower concentration, meaning more units are needed to reach the same mg amount, which can exceed a syringe’s barrel capacity at low concentrations and high mg amounts.
- Vial size. For a fixed water volume, concentration is directly proportional to vial size — a 20 mg vial reconstituted with 1 mL is twice the concentration of a 10 mg vial reconstituted the same way.
- Syringe calibration. Every figure above assumes a U-100 syringe (100 units = 1 mL), the standard for peptide research (see the syringes and injection guide). A different calibration — U-40, for instance — would report a different units figure for the identical physical volume; it does not change the concentration or the mg delivered.
How long does reconstituted retatrutide last?
Retatrutide has no manufacturer label of any kind — not for the lyophilized powder, and not for a reconstituted solution. ClinicalTrials.gov’s record for retatrutide’s pre-approval expanded-access program describes it as “an investigational GLP-1/GIP/glucagon triple receptor agonist.”
No manufacturer, regulator or study has published a stability figure for reconstituted research-grade retatrutide, refrigerated or otherwise. A vendor’s own product page may state a shelf-life figure; that is the vendor’s claim, not an independently verified one.
FAQ
What is reconstitution?
Does the water volume change how much peptide is in the vial?
What syringe do the unit figures on this page assume?
Why doesn't this page say how much water to add or what dose to draw?
What if my vial's size isn't in the table below?
Is a “reta calculator” the same as a retatrutide calculator?
How much BAC water for a 5mg retatrutide vial?
How much BAC water for a 10mg retatrutide vial?
How much BAC water for a 12mg retatrutide vial?
How much BAC water for a 15mg retatrutide vial?
How much BAC water for a 20mg retatrutide vial?
How much BAC water for a 24mg retatrutide vial?
How much BAC water for a 30mg retatrutide vial?
How much BAC water for a 40mg retatrutide vial?
How much BAC water for a 48mg retatrutide vial?
How much BAC water for a 50mg retatrutide vial?
How much BAC water for a 60mg retatrutide vial?
How much BAC water for a 100mg retatrutide vial?
References
- ClinicalTrials.gov. Pre-approval Expanded Access of Retatrutide (LY3437943), NCT07629401. https://clinicaltrials.gov/study/NCT07629401
Affiliate disclosure: Prof. Peptide earns a commission on purchases and sign-ups made through its links and codes, at no extra cost to the buyer. Commissions never decide which vendors are listed, how they are ranked or verified, or what Prof. Peptide concludes.
Related pages
- RetatrutideRetatrutide (LY3437943) in people: phase 3 TRIUMPH and TRANSCEND results, the doses each trial used, side effects at each dose, what clinics and users report, and its…
- Retatrutide Dosage: Clinic Doses and Phase 3 Trial DosesRetatrutide dosage: what clinics publish (weekly injections of 2,000 to 12,000 mcg, 2 to 12 mg), the doses its Phase 2 and peer-reviewed Phase 3 trials used, side…
- Peptide Half-Life Chart: Semaglutide, Tirzepatide, Ipamorelin and MorePeptide half-lives at a glance: semaglutide about 7 days, tirzepatide about 5 days, retatrutide about 6 days, ipamorelin about 2 hours, PT-141 about 2.7 hours.
- Semaglutide Half-Life Calculator — Accumulation at ~1 WeekSemaglutide Half-Life Calculator — Accumulation at ~1 Week.
- Peptide, GLP-1 & TRT CalculatorsReconstitution, syringe-unit and half-life calculators for semaglutide, tirzepatide, retatrutide, testosterone and 25+ peptides.
Checked and updated
